Singapore markets close in 3 hours 22 minutes
  • Straits Times Index

    3,058.61
    -12.62 (-0.41%)
     
  • Nikkei

    30,500.05
    +176.75 (+0.58%)
     
  • Hang Seng

    24,034.11
    -886.65 (-3.56%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • BTC-USD

    45,778.16
    -2,190.50 (-4.57%)
     
  • CMC Crypto 200

    1,143.96
    -81.57 (-6.66%)
     
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow

    34,584.88
    -166.42 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.93 (-0.91%)
     
  • Gold

    1,750.40
    -1.00 (-0.06%)
     
  • Crude Oil

    71.39
    -0.58 (-0.81%)
     
  • 10-Yr Bond

    1.3700
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,534.12
    -14.39 (-0.93%)
     
  • Jakarta Composite Index

    6,061.41
    -71.84 (-1.17%)
     
  • PSE Index

    6,857.90
    -54.95 (-0.79%)
     

Why Cyclerion Therapeutics Is Crashing Today

·2-min read
Why Cyclerion Therapeutics Is Crashing Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of clinical-stage biotech Cyclerion Therapeutics (NASDAQ: CYCN) are down by an eye-popping 48% as of noon EDT Wednesday. The small-cap biotech's stock is crashing in response to a negative midstage trial result for its sickle cell disease candidate olinciguat. Sickle cell disease is a rare blood disorder with limited treatment options.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting